XML 11 R4.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Jun. 30, 2025
Mar. 31, 2025
Current assets:    
Cash and cash equivalents $ 1,956 $ 2,085
Short-term investments 950 740
Accounts receivable, net (including receivables from related parties of $401 and $279 as of June 30, 2025 and March 31, 2025, respectively) 1,315 1,107
Contract assets (including contract assets from related parties of $227 and $152 as of June 30, 2025 and March 31, 2025, respectively) 645 642
Prepaid expenses and other current assets 307 256
Total current assets 5,173 4,830
Non-current assets:    
Property and equipment, net 467 354
Operating lease right-of-use assets 328 320
Finance lease right-of-use assets 78 40
Equity investments (including investments held under fair value option of $297 and $300 as of June 30, 2025 and March 31, 2025, respectively) 570 565
Goodwill 1,626 1,620
Intangible assets, net 263 151
Deferred tax assets 425 401
Non-current portion of contract assets 220 346
Other non-current assets 245 305
Total non-current assets 4,222 4,102
Total assets 9,395 8,932
Current liabilities:    
Accrued compensation and benefits 137 140
Tax liabilities 93 124
Contract liabilities (including contract liabilities from related parties of $104 and $105 as of June 30, 2025 and March 31, 2025, respectively) 259 209
Operating lease liabilities 36 30
Other current liabilities (including payables to related parties of $10 and $11 as of June 30, 2025 and March 31, 2025, respectively) 512 426
Total current liabilities 1,037 929
Non-current liabilities:    
Non-current portion of accrued compensation 28 26
Deferred tax liabilities 55 41
Non-current portion of contract liabilities 742 702
Non-current portion of operating lease liabilities 339 316
Other non-current liabilities 187 79
Total non-current liabilities 1,351 1,164
Total liabilities 2,388 2,093
Commitments and contingencies (Note 12)
Shareholders’ equity:    
Ordinary shares, $0.001 par value; 1,097 shares authorized and 1,059 shares issued and outstanding as of June 30, 2025; and 1,088 shares authorized and 1,057 shares issued and outstanding as of March 31, 2025 2 2
Additional paid-in capital 2,921 2,922
Accumulated other comprehensive income (loss) 411 372
Retained earnings 3,673 3,543
Total shareholders’ equity 7,007 6,839
Total liabilities and shareholders’ equity $ 9,395 $ 8,932